Background: A history of smoking confers additional risk of complications following plastic surgical procedures, which may require hospital-based care to address. Objectives: To determine if patients with a smoking history experience higher rates of complications leading to higher hospital-based care utilization, and therefore greater healthcare charges, after common outpatient plastic surgeries. Methods: Using ambulatory surgery data from California, Florida, Nebraska, and New York, we identified adult patients who underwent common facial, breast, or abdominal contouring procedures from January 2009 to November 2013. Our primary outcomes were hospital-based, acute care (hospital admissions and emergency department visits), serious adverse events, and cumulative healthcare charges within 30 days of discharge. Multivariable regression models were used to compare outcomes between patients with and without a smoking history. Results: The final sample included 214,761 patients, of which 10,426 (4.9%) had a smoking history. Compared to patients without, those with a smoking history were more likely to have a hospital-based, acute care encounter (3.4% vs 7.1%; AOR = 1.36 [1.25-1.48]) or serious adverse event (0.9% vs 2.2%; AOR = 1.38 [1.18-1.60]) within 30 days. On average, these events added $1826 per patient with a smoking history. These findings were consistent when stratified by specific procedure and controlled for patient factors. Conclusions: Patients undergoing common outpatient plastic surgery procedures who have a history of smoking are at risk for more frequent complications, and incur higher healthcare charges than patients who are nonsmokers.
commonly performed plastic surgery procedures in the United States. 8, 9 While some smoking-related complications can be treated in the outpatient setting with little time or economic cost to the patient, others may prompt patients to seek care in hospital emergency departments, or even require a hospital admission. This use of hospital-based, acute care in the postoperative period has been previously studied in the plastic surgery population. For outpatient plastic surgery patients treated in ambulatory surgery centers or hospital-based outpatient departments, nearly 4% will visit an emergency department or require hospital admission within 30 days of discharge. 10 These additional healthcare encounters may be costly for patients who are commonly self-pay 11 while simultaneously causing adverse psychological effects.
Despite the known adverse effects of smoking in the perioperative period, the frequency of hospital-based, acute care utilization and the associated healthcare charges attributable to smoking among patients undergoing common outpatient plastic surgeries are largely unknown. Therefore, we conducted this study to describe and quantify the relationship between smoking status, the frequency of emergency department visits and hospital admissions (hospital-based, acute care episodes), and overall charges in the 30-day period following outpatient plastic surgery. Based on prior studies showing higher rates of complications in this population, we hypothesized that postprocedure healthcare utilization and overall charges would be higher among the smoking population.
METHODS
We conducted a retrospective cohort study using discharge data from the 2009 to 2013 California, Florida, Nebraska, and New York ambulatory surgery, inpatient, and emergency department databases. [12] [13] [14] [15] These states were selected because they: (1) have large populations; (2) are geographically diverse; (3) have heterogeneous populations; (4) have available ambulatory surgery, emergency department (ED), and hospital inpatient databases; and (5) contain the variables necessary to follow patients over time and across healthcare settings. The databases are collected at the state-level, processed and standardized at the federal level, and ultimately made available to researchers through the Healthcare Cost and Utilization Project (HCUP). These data are a census of discharges from freestanding ambulatory surgery centers and hospital-based outpatient departments; inpatient discharges from acute care, nonfederal hospitals; and emergency department visits which do not result in hospital admission. Each discharge abstract contains up to 21 Current Procedural Terminology (CPT) or International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes and 15 diagnostic ICD-9-CM codes, as well as patient demographic, anticipated payer, and discharge disposition data. Additionally, databases for these states contain encrypted patient identifiers that allow for the longitudinal study of healthcare utilization over time and across healthcare settings.
Patient Selection
From the ambulatory surgery databases, we identified all discharges for state residents at least 18 years of age with a valid patient identifier who underwent facial plastic surgery (blepharoplasty, rhinoplasty, or face and forehead lift), breast surgery (breast reduction, mastopexy, or augmentation), abdominal contouring (liposuction or abdominoplasty), or a combination of procedures between January 1, 2009 and November 1, 2013 (N = 224,799; see Appendix 1 for CPT coding [available online as Supplementary Material at www.aestheticsurgeryjournal. com]). These surgeries were selected because they are among the most common outpatient plastic surgery procedures performed based on recent statistics released by the American Society for Aesthetic Plastic Surgery 8 and the American Society of Plastic Surgeons. 9 Next, we sequentially excluded discharges where the disposition was listed as missing, death, left against medical advice, or immediate transfer to an acute care hospital (N = 127). This ensured all patients survived to discharge and were "at risk" for subsequent analysis of healthcare utilization and associated healthcare charges. If a patient had more than one discharge meeting these same criteria within 30 days (N = 9666), we selected the first discharge for study.
Identifying Patients With a Smoking History
Patients were subgrouped according to smoking history. A smoking history was considered present if it was a listed diagnosis (ICD-9-CM codes 305.1x, V15.82) during the initial ambulatory surgery center encounter or during any hospital admission in the preceding 12 months. Prior studies evaluating the accuracy of these codes suggest high specificity but low sensitivity. 16 This suggests that when a history of smoking is coded, the patient likely has the diagnosis. However, the absence of a code does not completely exclude the diagnosis. If a relationship between smoking and poor outcomes exists, our results may underestimate the true effect of smoking due to misclassification of patients with a smoking history into the group without a smoking history.
Outcome Measures
We evaluated three 30-day outcomes: hospital-based acute care, serious adverse events, and cumulative healthcare charges. Hospital-based, acute care was defined as any hospital admission or emergency department visit within 30 days of discharge. Hospital admissions were identified from corresponding state inpatient databases, while emergency department visits not requiring hospital admission were identified from corresponding state emergency department databases. For this outcome, all encounters were included regardless of primary diagnosis. Serious adverse events were identified as a subset of these hospital-based, acute care encounters for specific diagnoses important to surgical patients: pulmonary failure, pneumonia, myocardial infarction, deep venous thrombosis or pulmonary embolism, acute renal failure, postoperative bleeding, surgical site infection, postoperative pain, or gastrointestinal bleeding. These diagnoses were selected because they have been previously used to study postoperative complications and have reasonable agreement with medical chart review. 17, 18 Cumulative healthcare charges were calculated by adding the total charges from the initial ambulatory surgery center encounter with all subsequent healthcare charges incurred from hospital-based, acute care encounters within 30 days of surgery. All healthcare charges were adjusted to 2015 US dollars using the medical component of the consumer price index.
Additional Data for Description and Risk Adjustment
At the time of ambulatory surgery center discharge, we recorded the patient's age, sex, and anticipated primary payer (Medicare, Medicaid, Private, Other), as well as the procedure(s) being performed. Using the inpatient and emergency department databases, we assessed the degree of chronic comorbidity according to the enhanced-Elixhauser 19 algorithm described by Quan et al 20 which identifies 31 chronic medical conditions. A condition was considered present if it was a listed diagnosis during the ambulatory surgery center discharge or at any inpatient or emergency department discharge in the previous 12 months. We collapsed similar diagnoses into clinically meaningful categories: cardiovascular diseases other than hypertension (ie, congestive heart failure, valve disease, arrhythmias, or peripheral vascular disease), hypertension, chronic respiratory disease, diabetes, hypothyroidism, and mental health diagnoses (ie, depression, psychoses, and substance abuse).
Statistical Analysis
First, patient sociodemographic and clinical characteristics were presented and compared between groups using t tests and chi-square tests for continuous and categorical variables, respectively. Second, logistic regression analyses were performed to calculate unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) to describe the association between a smoking history, hospital-based, acute care, and serious adverse events. All multivariable logistic regression models controlled for the sociodemographic and clinical variables previously described. Finally, the analysis of total, 30-day charges proceeded in several steps. Because the distribution of healthcare charges was not normally distributed, the variable was log transformed for analysis. This log transformed value served as the dependent variable in a linear regression model to determine the unadjusted and adjusted relationship between a smoking history and cumulative healthcare charges. In the adjusted models, the previously described covariates were augmented with variables representing the state where surgery was performed. The resultant parameter estimates were then back transformed with a smearing factor as described by Duan et al. 21 Because charges will be different across procedures, this analysis was stratified by procedure.
All P values were two-sided and considered significant at the P <0.05 level and all analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC). This study was approved in an expedited review by the University of Pennsylvania Institutional Review Board.
RESULTS
The final sample included 214,761 patients with 10,426 (4.9%) having a smoking history. The cohort was predominantly female (81.2% vs 17.1%) with a mean age of 52.1 years (range, 18-85 years). Most patients underwent facial plastic surgery, followed by breast surgery, and abdominal contouring procedures. Compared to patients without a smoking history, patients with a smoking history tended to be older (53.6 vs 52.1 years, P < 0.001) and were more often male (21.4% vs 16.9%, P < 0.001). Patients with a history of smoking were also more likely to have comorbid medical conditions including hypertension (38.5% vs 10.4%, P < 0.001), chronic obstructive pulmonary disease (20.5% vs 3.3%, P < 0.001), obesity (10.9% vs 2.9%, P < 0.001), and mental health diagnoses (18.0% vs 2.5%, P < 0.001; Table 1 ).
Description of Hospital-Based, Acute Care, and Serious Adverse Events
From the overall sample, 7585 patients (3.5%) experienced 8841 hospital-based, acute care encounters within 30 days of discharge. Most encounters (N = 6350; 71.8%) were emergency department visits that did not result in subsequent hospital admission. For emergency department visits, postoperative infections and acute postoperative pain were the most common diagnoses. For hospital admissions (N = 2491; 28.2%), postoperative infections, hematoma, and pulmonary embolus were the most common diagnoses. During the initial surgical encounter or at a subsequent postdischarge encounter, 2000 patients (0.9%) experienced at least one serious adverse event.
The majority of serious adverse events were related to surgical site infections (42.3%), postoperative bleeding (40.1%), and deep vein thromboses or pulmonary emboli (8.8%). The mean charge for an emergency department visit or hospital admission was $3929 (standard deviation, $5393) and $40,503 (standard deviation, $42,992), respectively.
Observed 30-Day Outcomes and Charges
In the unadjusted analysis, patients with a smoking history were more likely to have at least one hospital-based, acute care encounter (7.1% vs 3.4%, P < 0.001) or serious adverse event (2.2% vs 0.9%, P < 0.001) within 30 days of discharge (Table 2 ). This was consistent across procedure groups, where patients with a smoking history were more likely to have a hospital-based, acute care encounter within 30 days after facial plastic surgery (6.3% vs 2.5%, P < 0.001), breast surgery (7.5% vs 4.0%, P < 0.001), abdominal contouring (11.5% vs 5.5%, P < 0.001), or a combination of procedures (6.0% vs 3.6%, P =< 0.001). The higher frequency of postdischarge encounters contributed to higher charges across all individual procedure groups. For example, the difference in cumulative, 30-day charges for patients with a smoking history was highest among the cohort undergoing abdominal contouring ($11,362) and smallest among the cohort undergoing facial plastic surgery ($2875; Figure 1 ).
Adjusted 30-Day Outcomes and Charges
In the adjusted analysis, a smoking history remained independently associated with more frequent hospital-based, acute care encounters (OR = 1.36 [1.25-1.48]) and serious adverse events (OR = 1.38 [1.18-1.60]). However, the larger differences noted in the unadjusted analysis were partially attenuated by accounting for differences in the patient population (Table 2 ). Similar to the unadjusted analysis, patients with a smoking history experienced higher 30-day charges across all procedure groups (Figure 2 ).
DISCUSSION
Patients with a smoking history who undergo common elective facial cosmetic, breast, abdominal contouring, or a combination of these surgeries in the ambulatory setting are at higher risk for serious complications, and more frequently require hospital-based, acute care within 30 days of discharge than their nonsmoking peers. Most of these encounters were emergency department visits for wound infections and difficulty managing postoperative pain.
Smoking was found to be associated with a similar complication profile as seen in nonsmokers, but at a higher rate. The only difference was a higher rate of bronchitis exacerbation in the smoking population. This increase in hospital-based, acute care utilization after discharge contributes to higher average healthcare charges among the smoking population within 30 days of surgery. While prior studies in the plastic surgery literature have described an increased incidence of postoperative complications among patients with a smoking history, the current study translates these findings into economic terms. We found that patients with a smoking history incurred cumulative healthcare charges that were, on average, $1826 per person higher than patients without a smoking history. This increase in overall charges is consistent across all procedures studied, and remains significant after controlling for medical comorbidities, regional differences, and patient demographics. Because patients undergoing elective plastic surgery are often "self-pay" or have private insurance, they may be exposed to some degree of financial responsibility associated with these additional encounters. Therefore, the results from the current study may serve two purposes: (1) to provide additional education and motivation for patients with a smoking history to be compliant with perioperative smoking cessation; and (2) to quantify the opportunity cost surgeons face if they operate electively on a smoker.
Despite our understanding of the effects of smoking on surgical outcomes and the benefits of smoking cessation in the perioperative period, there is little standardization in the management of patients undergoing elective procedures who are current smokers. This may be attributed to physician attitudes regarding smoking, difficulty identifying patients who are current smokers, inconsistency in the literature regarding the optimal duration of abstinence preoperatively and postoperatively, and difficulty convincing or aiding patients to abstain from smoking. Though smoking is known to increase wound healing and infectious complications, 22, 23 the duration of cessation to gain maximum effect is unknown. Common practice is for surgical candidates to abstain from smoking for 4 weeks prior to surgery, as this has been shown to reduce infectious complications without increasing pulmonary complications. [24] [25] [26] Therefore, we recommend at least four weeks of preoperative smoking cessation for any patient undergoing an elective cosmetic procedure in the outpatient setting.
While smoking cessation should be encouraged, it is not always easy to identify patients who are active tobacco users. Approximately 26% of patients will deceptively self-report as nonsmokers or underreport the number of cigarettes smoked, 27 and 75% of patients who report abstinence from tobacco will smoke in the preoperative period. 6 Urine cotinine testing is a simple, inexpensive, and reliable method for identifying tobacco use in current smokers. Patients who are former smokers and those suspected of use should be urine cotinine tested at regular intervals leading up to surgery. Positive tests in patients undergoing procedures where a random pattern flap is created should have their surgeries delayed until they have stopped active use. Active smoking in the context of other procedures warrants individualized assessment and decision making. Acute postoperative pain was a common diagnosis for hospital-based acute care among patients with a history of smoking. This may be related to the complex, and poorly understood relationship that exists between smoking and pain. Acute nicotine exposure appears to have analgesic effects in human and animal models. However, chronic use mediates tolerance and causes hyperalgesia, which cessation does not appear to alleviate. It is hypothesized that nicotine exerts its effects through dopamine, opioid, serotonin, and acetylcholine receptors and the nucleus accumbens of the brain. Long-term smokers experience increased intensity and frequency of both chronic and acute pain, which leads to worse outcomes. Identifying current and former smokers preoperatively should prompt the use of multiple modalities such as long-acting local anesthetics, anti-inflammatories, GABA analogues, narcotics, and pain management referrals which could potentially reduce the frequency of emergency room utilization for pain control.
Similarly, there are well documented and complex relationships between tobacco use and mental health diagnoses. Tobacco use and mental health diagnoses are known to coexist at high rates, and this combination may synergistically increase complication rates and healthcare utilization, although this was not specifically evaluated in the current study. The independent influence of mental health diagnoses on and healthcare utilization has been studied by Wimalawansa et al who noted a threefold increase in hospital-based acute care utilization among patients with mental health diagnoses. 10 Patients who have a mental health diagnosis may interpret the postoperative setting differently; have difficulty complying with postoperative instructions; or lack the necessary social support to successfully navigate the postoperative period. All of these factors may contribute to higher rates of hospital-based acute care in this population. It is important to evaluate and address patients' mental health issues, and tailor their preoperative counseling to help them better understand perioperative expectations and instructions.
To the best of our knowledge, this is the first study to evaluate and quantify the increase in healthcare utilization and financial impacts of smoking in the ambulatory setting. However, this study is not without limitations. First, the identification of patients with a smoking history in administrative data can be challenging and associated ICD-9 codes likely have a high specificity and low sensitivity. For instance, when a history of smoking is coded, the patient likely has the diagnosis, however, the absence of a code does not exclude the diagnosis. Our results may underestimate the true incidence of smoking, potentially only capturing those who smoke heavily or who have smoking related complications such as chronic obstructive pulmonary disease (COPD) (as evidenced by a 20.5% incidence of COPD in our sample). It is unclear what the effects of more accurate identification of smoking status would be on our outcomes. Second, we have focused on the inpatient hospital and emergency department setting, as suits the available data. However, complications may occur which were treated in the surgeon's office. Therefore, our results should be interpreted as the frequency of complications resulting in hospital-based, acute care. Finally, patients with a smoking history frequently have comorbid medical conditions, which can also contribute to more frequent postoperative complications. To this end, we have attempted to adjust for these competing comorbidities through regression analyses.
CONCLUSIONS
In conclusion, patients with a smoking history who undergo common outpatient plastic surgeries experience a higher incidence of serious complications and more frequently require hospital-based, acute care within 30-days of discharge which contribute to higher healthcare charges in the perioperative period. It is important that patients undergoing elective outpatient plastic surgery be advised of both the physical and financial consequences of smoking. We recommend smoking cessation a minimum of 4 weeks prior to surgery with urine cotinine testing at regular intervals preoperatively. We also recommend multimodality treatment of postoperative pain in the population of former smokers. The focus of future studies should be on the appropriate time frame of cessation to limit postoperative complications and the best pain management regimens to manage postoperative pain in current and former smokers.
